What's the Cost of Breast cancer Diagnosis and Treatment in Republic of Korea?
Breast cancer treatment cost in Republic of Korea typically starts with essential diagnostics like a PET/CT scan, which costs $1,100 to $1,400. Primary surgical interventions such as a mastectomy range from $3,500 to $14,000, while a lumpectomy runs from $8,000 to $12,000. Total expenses depend on the cancer stage, robotic technology use, and clinic tier, offering 30–50% savings compared to the US. Seoul and Incheon are the leading cities for oncology care.
Typical Breast Cancer Treatment Costs in Republic of Korea
- PET/CT scan: $800 – $1,500
- Biopsy: $350 – $380
- Consultation with an oncologist: $40 – $75
- Breast ultrasound: $90 – $190
- Mastectomy: $3,500 – $14,000
- Lumpectomy: $8,000 – $12,000
- Breast reconstruction surgery: $8,000 – $10,000
- Chemotherapy for breast cancer: $3,000 – $13,000
- Radiotherapy for breast cancer: $15,000 – $15,500
- CyberKnife: $14,000 – $19,000
Bookimed Expert Insight: Patients seeking high-precision surgery benefit from centers like Samsung Medical Center. They utilize the Da Vinci robotic system for complex cases. For those prioritizing aesthetic outcomes, Ewha Womans University Medical Center is ideal. This women-only facility focuses on minimally invasive operations with small incisions. Large-scale multidisciplinary care is best accessed at Asan Medical Center. It serves over 2,500 inpatients daily with high-volume surgical expertise.
| Republic of Korea | Turkey | Austria | |
|---|---|---|---|
| Tomotherapy | ≈ $9,000 | from $8,400 | ≈ $9,500 |
| Resveratrol IV Therapy | ≈ $350 | ≈ $120 | ≈ $250 |
| Radiotherapy for breast cancer | from $15,000 | from $4,000 | from $6,600 |
| Radiation therapy for colorectal cancer | ≈ $9,000 | from $6,000 | from $6,600 |
| Proton therapy for breast cancer | ≈ $24,000 | ≈ $28,000 | ≈ $24,000 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Breast cancer treatment and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Breast cancer treatment and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Breast cancer treatment journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Breast cancer Treatment Centers in Republic of Korea: 13 Verified Options and Prices
Korea University Anam Hospital
Jung Seung-pil







Get a Medical Assessment for Breast cancer Treatment in Republic of Korea: Consult with 17 Experienced Doctors Now
View all Doctors
Lee Jihyeon
Dr. Lee Jihyeon is a breast and thyroid surgeon. He has expertise in benign and malignant breast diseases, oncoplastic breast surgery, and Mammotome biopsy. He also treats thyroid and parathyroid diseases. He practices pulmonary intensive care (critical care medicine).
He earned his M.D. from Yonsei University College of Medicine. He completed an internship and a general surgery residency at Yonsei University Severance Hospital. He also pursued a short-term fellowship at the Cancer Institute Hospital of JFCR in Japan.
His past roles include Chief of Surgery at Incheon Christian Hospital and Attending Surgeon at Cheil General Hospital. He served as Director of the Breast Center and as Chairman and Chief of Surgery at Samsung Cheil Hospital. He was Chairman of Surgery and Vice President of Medical Affairs at Cheil General Hospital. He also served as Clinical Professor of Surgery at Gangnam CHA Hospital, CHA University.

Kim Wan Song
Dr. Wan‑Sung Kim, MD, PhD, is Director of the Thyroid Center and an Associate Professor of Surgery at Myongji Hospital, an educational partner of Hanyang University. He is a breast and thyroid surgeon. He treats cancer and benign disease and focuses on minimally invasive thyroid and adrenal surgery.
Expertise: endoscopic and robotic thyroidectomy (transoral, axillary-areolar), thyroid radiofrequency ablation, ethanol ablation for thyroid lesions, and endoscopic or robotic adrenal tumor surgery.
He previously served as Head of Surgery at Myongji Hospital and Chuncheon Gangnam Hospital. He completed his residency and a breast and thyroid fellowship at Myongji. He holds an MD and MS from Catholic Kwandong University and a PhD from Kangwon National University. He is a member of the Korean Association of Thyroid and Endocrine Surgeons, the Korean Breast Cancer Society, the Korean Surgical Society, and the Korean Surgical Ultrasound Society.

Shin Hyuk Jai
Dr. Hyuk‑Jai Shin, MD, PhD, is a Clinical Professor of Surgery at Myongji Hospital in South Korea. He is also Director of the Breast Center and Vice President for Medical Affairs. His work focuses on breast cancer, benign breast disease, robotic and endoscopic breast surgery, and systemic therapy. He chairs the Korean Breast Cancer Society group for robotic and endoscopic minimally invasive surgery. He is a full member of ASCO.
He earned his MD and PhD from Dankook University. He completed a breast fellowship and served as a principal proteomics researcher at Seoul National University Hospital. He received endoscopic training at Kameda Hospital in Japan. He was an exchange professor at the University of Melbourne and a visiting surgeon at the Peter MacCallum Cancer Centre. He previously led the Breast & Thyroid Center and the Precision Medicine Center at Myongji Hospital. His publications include first‑author chapters in Translational Research in Breast Cancer (Chapter 30, pp. 567–590, Springer) and the Textbook of Surgical Ultrasound (Chapter 3‑3, VABB). He also co‑authored a nationwide VABB survey (Anticancer Research, 2012; 32(12):5459–64).

An Song Yeol
Reviews about Bookimed: Discover Patients' Insights
All reviewsRelated Articles
View more
Breast cancer detection
Written by Veronika Kazina

Breast cancer: symptoms, causes, and prevention
Written by Veronika Kazina

Types of breast cancer
Written by Veronika Kazina

Breast examination. Interview with the famous professor. Part 1
Written by Veronika Kazina

Organ-preserving surgeries for breast cancer treatment in Israel
Written by Veronika Kazina
Share this content
Video Stories from Bookimed Patients
Anna Leonova
Expert Overview about Breast cancer Treatment in Republic of Korea
What makes South Korea a top destination for breast cancer treatment?
South Korea is a global leader in breast cancer care, maintaining a 94.7% five-year survival rate that rivals the United States. This success stems from advanced robotic surgery, immediate oncoplastic reconstruction, and a fast-track system that typically starts treatment within 2 weeks of diagnosis at JCI-accredited Seoul centers.
- Survival rates: Korea reports a 94.7% five-year survival rate, exceeding many Western nations.
- Surgical precision: Surgeons at Korea University Anam Hospital pioneered robotic breast reconstruction with sub-centimeter incisions.
- Integrated care: Centers like Samsung Medical Center coordinate multidisciplinary teams for same-day diagnostic results.
- Aesthetic focus: Oncoplastic surgery, including nipple-sparing mastectomy and immediate reconstruction, is a standard clinical protocol.
Bookimed Expert Insight: Data from top-tier Seoul hospitals reveals a major shift toward scar-minimization. While many global centers treat reconstruction as a secondary phase, Korean institutions like Ewha Womans University Medical Center prioritize simultaneous tumor removal and aesthetic restoration. This approach reduces total anesthesia time and often results in higher patient satisfaction scores regarding body symmetry and psychological recovery.
Patient Consensus: Patients note that cosmetic discussions regarding scar placement and nipple preservation happen during the very first consultation. Many appreciate having dedicated English-speaking coordinators who manage everything from airport transfers to pharmacy visits during their three-week stay.
What specialized techniques are routinely used for breast cancer surgery in South Korea?
South Korea specializes in robot-assisted nipple-sparing mastectomy and oncoplastic surgery, prioritizing both oncological clearance and aesthetic preservation. Surgeons routinely use the Da Vinci SP system for single-port access through the armpit, while indocyanine green fluorescence improves the accuracy of sentinel lymph node biopsies.
- Robotic mastectomy: Performs nipple-sparing procedures through a single 3-5 cm incision.
- Oncoplastic surgery: Combines tumor removal with immediate glandular reshaping to prevent deformities.
- Fluorescence mapping: Uses indocyanine green instead of blue dye for precise nodal staging.
- Endoscopic surgery: Facilitates tumor removal and reconstruction with minimal tissue trauma and scarring.
Bookimed Expert Insight: Data from top-tier Seoul facilities like Asan Medical Center shows that robotic reconstruction can reduce scar size to one-tenth of traditional open surgery. Interestingly, clinics like Ewha Womans University Medical Center have prioritized these aesthetic outcomes since 1986. This long-term focus explains why Korean surgeons are specifically adept at volume displacement techniques for smaller breast sizes.
Patient Consensus: Patients describe the immediate reconstruction as life-changing because it preserves the breast's natural shape. They often note that procedures are completed in under 2 hours with significantly faster healing than they expected.
What are the typical in-country timeline and length of stay for surgery-based treatment?
Surgical treatment for breast cancer in South Korea typically requires an in-country stay of 10 to 14 days. This timeline accounts for pre-operative diagnostics, the surgical procedure at accredited centers in Seoul or Incheon, and critical post-operative monitoring before clearing patients for international travel.
- Pre-operative phase: Diagnostics including PET-CT and biopsies usually take 1–3 days after arrival.
- Hospital stay: Inpatient recovery after mastectomy or reconstruction lasts approximately 5–7 days.
- Post-operative monitoring: Patients remain near the clinic for 5–10 days for drain removal.
- Travel clearance: Surgeons generally recommend waiting 10–14 days before flying to manage risks.
Bookimed Expert Insight: Data from leading Seoul centers like Korea University Anam Hospital shows a trend toward integrating robotic breast reconstruction. This technology can reduce scarring by 90% compared to traditional methods. Patients opting for these minimally invasive techniques often report faster initial recovery, though the mandatory buffer for drain management remains 10 days.
Patient Consensus: Patients note that staying in a hotel near the hospital is essential for frequent wound checks. Many survivors emphasize that budgeting a full 2 weeks prevents stress if minor delays occur with laboratory results.
How can international patients coordinate care, visas, and language support in Seoul?
International patients coordinate care through dedicated international healthcare centers at major hospitals like Samsung Medical Center or Severance Hospital. These hubs manage hospital invitations for C-3-3 or G-1-10 medical visas, schedule specialist appointments, and provide professional medical interpreters for complex oncology consultations and surgeries.
- Care coordination: International departments streamline appointments, airport pickups, and medical documentation.
- Visa support: Clinics issue mandatory certificates of confirmation for specialized medical visa applications.
- Language services: Hospitals provide on-site interpreters for English, Russian, Chinese, and Arabic speakers.
- Support centers: The Medical Korea Information Center offers one-stop arrival and departure consultations.
Bookimed Expert Insight: Patient data shows major centers like Severance Hospital and Samsung Medical Center serve millions of patients annually, creating highly efficient administrative pipelines. For breast cancer, requesting a teleconsultation first is a smart move to secure the official invitation letter. This often speeds up the medical visa process to just 1–2 weeks compared to months for independent applications.
Patient Consensus: Patients note that hospital-provided interpreters are essential for oncology because general translation apps fail with medical jargon. Many emphasize that using hospital shuttles is better than the subway when dealing with post-treatment fatigue.
What is the median wait time for first definitive breast cancer treatment at leading Seoul hospitals?
The median wait time for first definitive breast cancer treatment in Seoul is approximately 16 days for local residents. Patients traveling from other regions face longer intervals, typically 24 to 27 days. Leading tertiary centers like Samsung Medical Center generally initiate treatment within 30 days of diagnosis for 90% of patients.
- Regional variation: Local Seoul residents experience the shortest wait times at approximately 16 days.
- Traveler delays: Patients from metropolitan areas like Incheon average 27 days before starting treatment.
- Hospital volume: High caseloads at Big 5 hospitals like Asan Medical Center impact surgical scheduling.
- Treatment type: Primary chemotherapy often starts faster than surgery due to limited operating room availability.
Bookimed Expert Insight: While official data shows 16-day medians, top-tier centers with massive patient volumes like Severance Hospital and Samsung Medical Center often prioritize international cases for faster throughput. Professional coordinators can typically bypass local primary care referrals, which often saves patients about 5–7 days of administrative delay during the initial diagnostic phase.
Patient Consensus: Patients note that getting biopsy results within 2 days is common at major centers like Samsung. Many emphasize that having digitalized records ready before arrival can cut another 3–5 days off the total wait time.
Are National Health Insurance (NHI) subsidies available to foreign residents for cancer care?
Foreign residents in the Republic of Korea access National Health Insurance subsidies for cancer care after 6 months of residency or immediately upon employment. The special co-payment reduction program for severe diseases reduces out-of-pocket costs for cancer patients to just 5% of medical bills.
- Eligibility criteria: Requires Alien Registration Card (ARC) and 6 months of local residency.
- Cost reduction: Severe disease registry reduces standard 20% co-payments down to 5%.
- Coverage scope: Subsidies apply to surgery, radiotherapy, chemotherapy, and essential diagnostic imaging.
- Screening benefits: Free or 90% subsidized breast cancer screenings available for eligible beneficiaries.
Bookimed Expert Insight: While private facilities like Samsung Medical Center or Severance Hospital serve millions of patients, the 5% co-payment rule only triggers after official registration in the National Health Insurance Service (NHIS) severe disease database. Patients should ensure their hospital coordinator submits the registration form immediately after diagnosis to avoid paying the standard 20% rate for initial intensive treatments.
Patient Consensus: Patients note that while the 6-month waiting period is strict for some visa types, the high quality of care and English-speaking translation services at major Seoul hospitals make the bureaucratic process manageable.

















